News|Articles|October 7, 2024
A Streamlined Platform Process to Accelerate Biotherapeutics from Gene to Clinic
Author(s)Catalent
Harmonizing technological innovation and a platform approach in biomanufacturing can reduce time and cost barriers to produce stable, high-expressing antibody-based therapeutics
Related Content
Trending on Pharmaceutical Technology
1
PharmTech Weekly Roundup—June 5, 2026
2
EMA Collaborates with African Regulators on Ebola Treatments
3
A Pharma Manufacturing Blueprint from Delaware’s Innovation Vision
4
Faster Doesn’t Mean Easier: Development Impacts of a New Biosimilar Regulatory Landscape
5